TXG Stock Performance and Key Statistics

TXG has a current P/E ratio of -187.35

The TXG stock has a trailing twelve month price-to sales (P/S) ratio of 6.33 while its price-to-book (P/B) value is 5.02.

TXG's price-to-free-cashflow (P/FCF) ratio is 33.1, an indicator that is currently being trending upward.

Based on TXG's recent bid, its distance from 20 days simple moving average is 15.23%. It is 16.33% apart from 50 days simple moving average, and it is 52.91% apart from 200 days simple moving average.

The 52-week high for TXG is $36.59 which is -6.07% away from the current price level whereas the distance of that from the 52-week low of $10.63 stands at 226.4%.

The performance of TXG stock was not encouraging with most of its significant price indicators in green. 10x Genomics, Inc.(NASDAQ: TXG) shares have moved downward -3.25% or - $1.07 in the latest trading session and have gained 35.19% year-to-date (YTD). The stock has gained nearly 46.12% over the past year. After moving 86.39% over the trailing 3-month period, the stock is 91.07% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 11.36% a week and 40% a month.

The current 14-day RSI for TXG stock is 65.42. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, 10x Genomics, Inc. (TXG) has a 14-day ATR of 1.27.

After closing at $32.94 with 126.96M of its shares outstanding, the current enterprise value of TXG is roughly 3.03B.

10x Genomics, Inc. (NASDAQ: TXG) is up 46.12% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 9.62%. TXG stock price is also up 35.19% on its value in year-to-date trading.

The number outstanding shares of TXG is 126.96M, and of these 87.83% shares are freely available for trading. On average, TXG stock has traded 3.71M shares per day for the past 10 days. A total of 3.29M shares changed hands during the last trading session with the average session volume of 2.83M shares.